Bleeding disorder resident survival guide: Difference between revisions
Line 32: | Line 32: | ||
{{familytree | C01 | | C02 | |!| | | | | | |!| | | | |C01=Genetic|C02=Acquired}} | {{familytree | C01 | | C02 | |!| | | | | | |!| | | | |C01=Genetic|C02=Acquired}} | ||
{{familytree | |!| | | |!| | |!| | | | | | | | | }} | {{familytree | |!| | | |!| | |!| | | | | | | | | }} | ||
{{familytree | D01 | | D02 | |!| | | | | | | | | | | | | | | |D01=❑ [[Glanzmann's thrombasthenia]]<br> | {{familytree | D01 | | D02 | |!| | | | | | | | | | | | | | | |D01=<div style="float: left; text-align: left; width: 20em; padding:1em;">❑ [[Glanzmann's thrombasthenia]]<br> | ||
❑ [[Bernard-Soulier syndrome]]<br> | ❑ [[Bernard-Soulier syndrome]]<br> | ||
❑ [[Von Willebrand's disease]]|D02=❑ [[Myeloproliferative disorders]]<br> | ❑ [[Von Willebrand disease|Von Willebrand's disease]]|D02=❑ [[Myeloproliferative disorders]]<br> | ||
❑ [[Uremia]]<br> | ❑ [[Uremia]]<br> | ||
❑ Drugs (NSAIDs, [[aspririn]], [[clopidogrel]], etc.)<br> | ❑ Drugs (NSAIDs, [[aspririn]], [[clopidogrel]], etc.)<br> | ||
Line 47: | Line 47: | ||
{{familytree | | | | | | E01 | | | E02 | | E03 | | | | |E01=Genetic|E02=Acquired|E03=Prothrombotic }} | {{familytree | | | | | | E01 | | | E02 | | E03 | | | | |E01=Genetic|E02=Acquired|E03=Prothrombotic }} | ||
{{familytree | | | |,|-|-|^|-|.| | |!| | | |!| | | | |}} | {{familytree | | | |,|-|-|^|-|.| | |!| | | |!| | | | |}} | ||
{{familytree | | | {{familytree | | | |!| | | | |!| | F04 | | F03 | | | | | | | |F04=<div style="float: left; text-align: left; width: 20em; padding:1em;">❑ Pro[[hemorrhage|hemorrhagic]] liver diseases<br> | ||
❑ [[Vitamin K deficiency]]<br> | ❑ [[Vitamin K deficiency]]<br> | ||
❑ Drug-induced such as [[warfarin]] and [[heparin]]<br> | ❑ Drug-induced such as [[warfarin]] and [[heparin]]<br> | ||
Line 57: | Line 54: | ||
❑ [[Immunoglobulin]] mediated Factor Deficiency (VIII, V, XIII, X)<br> | ❑ [[Immunoglobulin]] mediated Factor Deficiency (VIII, V, XIII, X)<br> | ||
❑ [[Hyperfibrinolysis]]<br> | ❑ [[Hyperfibrinolysis]]<br> | ||
❑ [[Venom]] induced<br>}} | ❑ [[Venom]] induced|F03=<div style="float: left; text-align: left; width: 20em; padding:1em;">❑ [[Heparin Induced Thrombocytopenia]]<br> | ||
{{familytree | | | | | | | | | | | | | | | | | | | | |}} | ❑ [[Antiphospholipid Antibody Syndrome]]<br> | ||
{{familytree | | | | | | | | | | | | | | | | | | | | |}} | ❑ [[Microvascular Thrombosis]] ([[warfarin]] induced skin [[necrosis]]) }} | ||
{{familytree | | F01 | | | | F02 | | | | | | | | | | | | | F01=Hemorrhagic disorders|F02=Hypercoaguable disease}} | |||
{{familytree | | |!| | | | | |!| | | | | | | | | | | |}} | |||
{{familytree | | G01 | | | | G02 | | | | | | | | | | | | |G01=<div style="float: left; text-align: left; width: 20em; padding:1em;">❑ [[Factor VIII deficiency]]<br> | |||
❑ [[Factor IX Deficiency]]<br> | |||
❑ [[Von Willebrand disease|Von Willebrand factor deficiency]]<br> | |||
❑ Factor XI deficiency <br> | |||
❑ Factor II, V, VII, X deficiency (Common Pathway Proteins)<br> | |||
❑ [[Factor XIII]] deficiency and [[fibrinogen]] deficiency|G02=<div style="float: left; text-align: left; width: 20em; padding:1em;"><br>❑ [[Antithrombin III deficiency]]<br> | |||
❑ [[Protein C deficiency]] and [[protein S deficiency]]}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | |}} | {{familytree | | | | | | | | | | | | | | | | | | | | |}} | ||
{{familytree | | | | | | | | | | | | | | | | | | | | |}} | {{familytree | | | | | | | | | | | | | | | | | | | | |}} | ||
{{familytree/end}} | {{familytree/end}} | ||
== Diagnosis == | == Diagnosis == |
Revision as of 15:13, 30 October 2020
Bleeding disorder Resident Survival Guide |
---|
Overview |
Causes |
FIRE |
Diagnosis |
Treatment |
Do's |
Don'ts |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Javaria Anwer M.D.[2]
Overview
Causes
Causes of bleeding disorders | |||||||||||||||||||||||||||||||||||||||||||||||
Platelet disorders | Coagulopathy | Vessel/ Supporting tissue defect | |||||||||||||||||||||||||||||||||||||||||||||
Genetic | Acquired | ||||||||||||||||||||||||||||||||||||||||||||||
❑ Myeloproliferative disorders ❑ Uremia | |||||||||||||||||||||||||||||||||||||||||||||||
Genetic | Acquired | Prothrombotic | |||||||||||||||||||||||||||||||||||||||||||||
❑ Prohemorrhagic liver diseases ❑ Vitamin K deficiency | |||||||||||||||||||||||||||||||||||||||||||||||
Hemorrhagic disorders | Hypercoaguable disease | {{{ }}} | |||||||||||||||||||||||||||||||||||||||||||||
❑ Factor VIII deficiency ❑ Factor IX Deficiency | |||||||||||||||||||||||||||||||||||||||||||||||
Diagnosis
The algorithm illustrates the approach to the diagnosis of bleeding disorder.[1][2][3]
Abbreviations: HEENT: Head, Eyes, Ears. Nose, and Throat exam; CBC: Complete blood count; APTT Partial thromboplastin time; CMP: Comprehensive metabolic panel; LFTs:Liver function tests
Boxes in red signify that an urgent management is needed.
History ❑ Demographics: Patient age, gender,and race to screen for inherited disorders.
❑ Past medical history: For the underlying disease. History of blood or blood components transfusion. Childhood history of epistaxis, bleeding post-circumcision, and umbilical stump bleeding may suggest an inherited bleeding disorder. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Physical exam Appearance of the patient Petechie, bruises, or hemorrhages ❑ Vital signs: Temperature; heart rate (tachycardia with regular pulse may demonstrate hypovolemia); respiratory rate, blood pressure (hypotension); and oxygen saturation may be low due to anemia. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Labs ❑ CBC with differential | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Soft tissue hematoma, deep internal hemorrhage, hemarthrosis | Superficial cutaneous or mucous membrane bleeding | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PT Normal, aPTT Prolonged | PT Prolonged, aPTT Normal | PT Prolonged, aPTT Prolonged | Platelet Count Low | Platelet Count Normal | |||||||||||||||||||||||||||||||||||||||||||||||||||||
•Factor VIII, IX, XI Deficiency •Von Willebrand Disease •Heparin contamination | •Factor VII deficiency •Vitamin K deficiency | •Check Thrombin time | •Idiopathic Thrombocytopenic Purpura (ITP) •Hereditary Platelet Disorder •Bone marrow failure | •Check PFA-100 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
{{{E01}}} | {{{E02}}} | {{{E03}}} | {{{E04}}} | {{{E05}}} | {{{E06}}} | {{{E07}}} | |||||||||||||||||||||||||||||||||||||||||||||||||||
Treatment
Do's
- A study by Wahlberg et al. demonstrated that the patient's perception of his/her own bleeding may be understated or exaggerated, so labs vital in the assessment of bleeding disorders.[4]
Don'ts
References
- ↑ Bashawri LA, Ahmed MA (May 2007). "The approach to a patient with a bleeding disorder: for the primary care physician". J Family Community Med. 14 (2): 53–8. PMC 3410146. PMID 23012146.
- ↑ Hayward CP (2005). "Diagnosis and management of mild bleeding disorders". Hematology Am Soc Hematol Educ Program: 423–8. doi:10.1182/asheducation-2005.1.423. PMID 16304414.
- ↑ Blanchette VS, Sparling C, Turner C (April 1991). "Inherited bleeding disorders". Baillieres Clin Haematol. 4 (2): 291–332. doi:10.1016/s0950-3536(05)80162-3. PMID 1912663.
- ↑ Wahlberg T, Blombäck M, Hall P, Axelsson G (October 1980). "Application of indicators, predictors and diagnostic indices in coagulation disorders. I. Evaluation of a self-administered questionnaire with binary questions". Methods Inf Med. 19 (4): 194–200. PMID 7432180.